Armin Buchwald
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Armin Buchwald has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Karl Winkler
Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Freiburg, Freiburg, Germany
1 shared publication - Thomas Epting
Institute for Clinical Chemistry and Laboratory Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Hugstetterstraße 55, 79106 Freiburg, Germany
1 shared publication
Latest Publications
- Open Access
- 11 January 2012
- Published by Springer Nature in BMC Clinical Pharmacology
- Vol. 12 (1) , 2
Validation of an LC-MS/MS method to determine five immunosuppressants with deuterated internal standards including MPA
Therapeutic drug monitoring of immunosuppressive drugs in organ-transplanted patients is crucial to prevent intoxication or transplant rejection due to inadequate dosage. The commonly used immunoassays have been gradually undergoing replacement by mass spectrometry, since this physical method offers both a higher sensitivity and specificity. However, a switch should be carefully considered because it is a challenging procedure and needs to be thoroughly validated.
- 11 January 2012
- Published by Springer Nature in BMC Clinical Pharmacology
- Vol. 12 (1) , 2
Open AccessValidation of an LC-MS/MS method to determine five immunosuppressants with deuterated internal standards including MPA
Therapeutic drug monitoring of immunosuppressive drugs in organ-transplanted patients is crucial to prevent intoxication or transplant rejection due to inadequate dosage. The commonly used immunoassays have been gradually undergoing replacement by mass spectrometry, since this physical method offers both a higher sensitivity and specificity. However, a switch should be carefully considered because it is a challenging procedure and needs to be thoroughly validated.